The American Medical Association and five other medical societies recently filed an amicus brief with the U.S. Court of Appeals in support of a lower federal court ruling that invalidated patents held by Myriad Genetics on two genes, known as BRCA1 and BRCA2.
The associations contend that human genes should not be considered property and enabling the patenting of genes will harm opportunities for scientific research and medical care because research on specific genes could be limited.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access